Tag Archives: National Institutes of Health

Heads of NIH and FDA Update Congress on 21st Century Cures Act

On November 30, the House Committee on Energy and Commerce Committee held a hearing on implementation of the 21st Century Cures Act, signed into law a year ago. Scott Gottlieb, MD, Commissioner of the Food and Drug Administration (FDA), and Francis Collins, MD, PhD, Director of the National Institutes of Health (NIH), offered testimony about… Read More »

Is your research a clinical trial? The answer may surprise you!

Background In October 2014, the National Institutes of Health (NIH) announced a change in its definition of a clinical trial, to take effect in January 2015. The new definition, which applies only to NIH-funded clinical trials, reads: “A research study in which one or more human subjects are prospectively assigned to one or more interventions… Read More »

NIH Announces New Plans to Optimize Distribution of Grant Funding

The National Institutes of Health (NIH) unveiled on May 2 plans for a new policy designed to optimize distribution of grant funds across the research community. It will be implemented later this year. In a teleconference, Dr. Larry Tabak, DDS, PhD, the agency’s Principal Deputy Director,  noted that several key grants policy changes were put… Read More »

National Academies’ Next Generation Researchers Initiative gets underway

The first meeting of a National Academies of Science, Engineering, and Medicine study on the difficulties young biomedical researchers face trying to establish and maintain careers as independent scientists took place in Washington, DC, on January 9. The Next Generation Researchers Initiative aims to evaluate numerous factors affecting the transition to independent research careers, including… Read More »

Inside (the Beltway) Scoop

Congress Struggles with Decisions on Government Funding; Cures Legislation Passes House; FASEB-Led Effort Protects Funding for Research Grants Despite three weeks of negotiations, members of Congress are still no closer to reaching an agreement on how to fund the government once the current “continuing resolution” (CR) expires on December 9. House Speaker Paul Ryan’s plan… Read More »

Winners of 2016 FASEB BioArt competition announced

The Federation of American Societies for Experimental Biology (FASEB) is pleased to announce the winners of the fifth annual BioArt competition. This year’s 10 winning images and three videos represent a wide range of research in the biomedical and life sciences, from technology that may aid in recovery from spinal cord injury to a portrait… Read More »

FASEB president-elect speaks at congressional briefing on impact of CR

On November 29, Federation of American Societies for Experimental Biology (FASEB) President-Elect Thomas O. Baldwin, PhD, spoke at a Capitol Hill briefing organized by the American Society for Biochemistry and Molecular Biology (ASBMB). The event explored the impact that another “continuing resolution” (CR) would have on biomedical research. Dr. Baldwin acknowledged that it is critical… Read More »